SP1 antibodies target the SP1 transcription factor, a protein critical for regulating genes involved in cell growth, apoptosis, and immune responses . These antibodies are primarily used for:
Immunohistochemistry (IHC)
Western blotting (WB)
Immunoprecipitation (IP)
SP1 is a nuclear protein with a molecular weight of ~81 kDa, though observed bands often appear at 90–106 kDa due to post-translational modifications .
SP1 vs. 1D5 Antibodies: SP1 (rabbit monoclonal) demonstrates higher sensitivity than the 1D5 clone (mouse monoclonal) in detecting estrogen receptor (ER) in breast cancer. Discrepancy rates range from 8% to 16.9%, with SP1-positive/1D5-negative cases showing survival outcomes similar to double-positive cases .
Quantitative Performance:
Elevated SP1 levels correlate with advanced tumor stage, poor prognosis, and immunotherapy response in gastric cancer (GC) .
Immune Modulation: High SP1 expression associates with CD8+ T cell infiltration and M1 macrophage polarization in GC .
IHC: Antigen retrieval with EDTA pH 9.0 or citrate buffer pH 6.0 enhances SP1 detection .
WB: Recommended blocking with 5% non-fat milk to reduce background noise .
ER-Beta Cross-Reactivity: SP1 antibodies do not cross-react with ER-beta, ensuring specificity for ER-alpha in breast cancer diagnostics .
Transcriptional Regulation: SP1 binds GC-rich DNA motifs, modulating genes like PD-L1 and VEGF, which are critical in tumor immune evasion .
KEGG: ath:AT1G26355
STRING: 3702.AT1G26355.1